Truist Securities Maintains Buy on Tenet Healthcare, Raises Price Target to $155
Portfolio Pulse from Benzinga Newsdesk
Truist Securities has maintained its Buy rating on Tenet Healthcare (NYSE:THC) and raised the price target from $130 to $155.
July 15, 2024 | 2:17 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Truist Securities has maintained its Buy rating on Tenet Healthcare and increased the price target from $130 to $155, indicating strong confidence in the company's future performance.
The raised price target and maintained Buy rating from Truist Securities suggest a positive outlook for Tenet Healthcare, likely leading to increased investor confidence and a potential short-term price increase.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100